S. D. Bull et al. / Tetrahedron: Asymmetry 15 (2004) 3989–4001
3999
4.9. (3S,6S)-N,N0-Bis-(p-methoxybenzyl)-5,5-diallyl-6-
hydroxy-3-isopropyl-piperazine-2-one 18
4.11. (3S,6S)-N,N0-Bis-(p-methoxybenzyl)-5,5-dimethyl-
6-hydroxy-3-isopropyl-piperazine-2-one 21, (3S,6S)-
N,N0-bis-(p-methoxybenzyl)-3-isopropyl-6-methyl-pipera-
zine-2,5-dione 22 and (3S)-N,N0-bis-(p-methoxybenzyl)-3-
isopropyl-piperazine-2,5-dione 1
Treatment of 8 (1.00g, 2.32mmol) with allylmagnesium
chloride (2.50mL, 2M solution in THF, 5.0mmol)
according to the General procedure gave after chroma-
tography (silica, 1:1 ether/hexane) 18 as a colourless
Treatment of 8 (430mg, 1.00mmol) with methylmagne-
sium chloride (0.50mL, 3M in ether, 1.5mmol) accord-
ing to the General procedure gave oily crude mixture
oil as the first eluting compound (672mg, 60%).
23
D
½a ¼ À10:0 (c 1.05, CHCl3); tmax (film)/cmÀ1 3424,
2957, 2873, 1652 (NC@O), 1612, 1512, 1247; dH
(500MHz, CDCl3): 0.95 (d, 1H, J 6.8, CH3CHCH3),
1.26 (d, 1H, J 7.1, CH3CHCH3), 1.82 (dd, 1H, J 14.6,
7.4, CH2CH@CH2), 2.01 (m, 1H, (CH3CHCH3), 2.20
(dd, 1H, J 7.2 and 14.4, CH2CH@CH2), 2.43 (m, 2H,
CH2CH@CH2), 3.39 (d, 1H, J 17.4, ArCH2), 3.48 (d,
1H, J 1.7, 3-H), 3.55 (d, 1H, J 11.6, OH), 3.85 (s, 3H,
OMe), 3.85 (s, 3H, OMe), 4.17 (d, 1H, J 14.3, ArCH2),
4.30 (d, 1H, J 11.6, CHOH), 4.40 (d, 1H, J 17.4,
ArCH2), 5.03 (d, 1H, J 14.3, ArCH2), 5.08-5.12 (m,
4H, CH2CH@CH2), 5.68–5.74 (m, 1H, CH2CH@CH2),
5.74–5.87 (m, 1H, CH2CH@CH2), 6.87–6.93 (m, 4H,
aromatic H), 7.23–7.32 (m, 2H, aromatic H), 7.36–7.39
(m, 2H, aromatic H); dC (125MHz, CDCl3): 16.7,
21.6, 30.9, 34.5, 38.7, 47.8, 53.6, 55.3 · 2, 62.8, 71.3,
81.3, 113.8, 113.9, 119.2, 119.8, 127.0, 129.1, 130.5,
132.3, 133.5, 134.5, 158.3, 159.0, 169.2; m/z (APCI+)
479 (MH+, 18%), 357(4), 341(5), 121(100); [HRMS
(TOF, FI) found: M+, 478.2826. C29H38N2O4 requires
478.2832].
(400mg). Chromatography (silica, 1:1 ether/hexane)
23
afforded 21 as a clear oil (187mg, 44%). ½a ¼ À13:1
D
(c 1.05, CHCl3); tmax (film)/cmÀ1 3441(OH), 2959,
2934, 2872, 2834, 1651, 1511, 1245; dH (500MHz,
CDCl3): 0.81 and 0.93 (s, 3H, Me2C), 1.01 (d, 1H, J
6.9, CH3CHCH3), 1.24 (d, 1H, 7.1, CH3CHCH3), 2.02
(m, 1H, CH3CHCH3), 3.20 (d, 1H, J 1.7, 3-H), 3.40
(d, 1H, J 16.9, ArCH2), 3.44 (d, 1H, J 11.9, CHOH),
3.79 (s, 3H, OMe), 3.80 (s, 3H, OMe), 3.93 (d, 1H, J
16.2, ArCH2), 3.96 (d, 1H, J 14.2, ArCH2), 4.05, (d,
1H, J 11.9, CHOH), 5.21 (d, J 14.3, ArCH2), 6.82–
6.91 (m, 4H, aromatic H), 7.20–7.23 (m, 2H, aromatic
H), 7.28–7.31 (m, 2H, ArH); dC (125MHz, CDCl3):
16.1, 17.4, 21.5, 26.1, 31.5, 47.0, 53.0, 55.1, 55.2, 58.3,
70.5, 84.0, 113.8, 113.81, 127.5, 129.1, 130.4, 134.1,
158.3, 159.0, 169.1; m/z (APCI) 427 (MH+, 48%), 121
(100); [HRMS (CI) found: MH+, 427.2597.
C25H35N2O4 requires 427.2597].
Further elution gave cis-methyl 22 as a colourless oil
23
D
(61mg, 14%). ½a ¼ À194 (c 1.00, CHCl3) [lit.4b À202
(c 0.89, CHCl3)]; dH (400MHz, CDCl3): 1.04 (d, 1H, J
6.9, (CH3CHCH3), 1.17 (d, 1H, J 7.00, CH3CHCH3),
1.55 (d, J 7.1, NCHCH3), 2.20 (m, 1H, CH3CHCH3),
3.74 (d, 1H, J 5.6, 3-H), 3.81 (s, 3H, OMe), 3.81 (s,
3H, OMe), 3.87 (d, 1H, J 14.8, ArCH2), 3.99 (q, J 7.5,
6-H), 4.00 (d, 1H, J 14.9, ArCH2), 5.11 (d, 1H, J 14.7,
ArCH2), 5.35 (d, 1H, J 14.8, ArCH2), 6.83–6.86 (m,
4H, aromatic H), 7.08–7.16 (m, 4H, aromatic H); m/z
(APCI) 411 (MH+, 90%), 303 (10), 121 (100). Spectro-
scopic data was identical to authentic material.
4.10. (3S,6S)-N,N0-4-Bis-(p-methoxybenzyl)-6-trimethyl-
siloxy-5,5-diallyl-3-isopropyl-piperazine-2-one 20
Compound 18 (26mg, 0.048mmol) and trimethylsilylim-
idazole (0.5mL) in dichloromethane (0.5mL) were stir-
red for 12h at room temperature then partitioned
between water and ether, the organic layer dried
(MgSO4) and solvent removed in vacuo. Chromatogra-
phy (silica, 1:9 ether–hexane) gave 20 as a colourless
solid (23mg, 77%). Mp 136ꢁC (ether/hexane). Found:
C, 69.6; H, 8.2; N, 5.1. C32H46N2O4Si requires C, 69.8;
Further elution gave 1 as a colourless solid (28mg, 7%).
dH (200MHz, CDCl3): 0.92 (3H, d, J 7.0, CH3CHCH3),
23
H, 8.4; N, 5.1; ½a ¼ À36:4 (c 1.03, CHCl3); tmax
D
(KBr disc) cmÀ1 2946, 1653 (NC@O), 1611, 1513,
1240; dH (400MHz, CDCl3): 0.31 (s, 9H, Si(CH3)3),
1.00 (d, 3H, J 6.7, CH3CHCH3), 1.14 (d, 3H, J 7.7,
CH3CHCH3), 1.52 (dd, 1H, J 14.5, 7.0, CH2CH@CH2),
1.81 (m, 1H, CH3CHCH3), 2.15 (dd 1H, J 14.5, 8.0
CH2CH@CH2), 2.32 (d, 2H, J 7.1, CH2CH@CH2),
3.31 (d, 1H, J 18.2, ArCH2), 3.45 (d, 1H, J 0.6Hz,
3-H), 3.61 (d, 1H, J 14.3, ArCH2), 3.80 (s, 3H, OMe),
3.81 (s, 3H, OMe), 4.45 (d, 1H, J 18.2, ArCH2),
4.45 (s, 1H, 6-H), 4.92 (m, 4H, CH2CH@CH2),
1.10 (3H, d, J 7.0, CH3CHCH3), 2.22 (1H, m,
CH3CHCH3), 3.75 (1H, d, J 5.0, 3-H), 3.80 (1H, d, J
17.0, 6-H), 3.81 (3H, s, OMe), 3.81 (3H, s, OMe), 3.85
(1H, d, J 15.0, ArCH2), 3.94 (1H, d, J 17.5, 6-H), 4.21
(1H, d, J 14.0, ArCH2), 4.82 (1H, d, J 14.0, ArCH2),
5.33 (1H, d, J 15.0, ArCH2), 6.85–7.19 (8H, m, aromatic
H). Spectroscopic data was identical to authentic
material.
4.12. (3S,6R)-N,N0-Bis-(p-methoxybenzyl)-3-isopropyl-6-
benzyl-piperazine-2,5-dione 24
5.43 (d, 1H,
J
14.3, ArCH2), 5.53–5.75 (m,
2H, CH2CH@CH2), 6.82–6.88 (m, 4H, aromatic
CH), 7.34 (m, 2H, aromatic CH), 7.43 (m, 2H, aro-
matic H). NOESY cross peak observed between
dH = 0.31 and dH = 1.00; dC (100MHz, CDCl3): 0.8,
16.8, 21.3, 31.5, 35.1, 37.4, 47.4, 53.1, 55.2 (· 2), 61.9,
71.2, 82.6, 113.2, 113.8, 118.7, 119.0, 127.1, 129.2,
Treatment of 8 (430mg, 1.0mmol) with benzylmagne-
sium chloride (1.20mmol, 0.60mL, 2M solution in
THF) according to the General procedure gave an oily
crude mixture. Chromatography (silica, 1:1 ether/hex-
ane) gave 24 as the first eluting compound (218mg,
23
D
130.4, 132.8, 134.0, 136.1, 157.9, 159.1, 170.6
;
45%). Mp 168ꢁC; ½a ¼ þ54:6 (c 1.09, CHCl3) [lit.4b
23
½a ¼ þ58:6 (c 0.99, CHCl3)]; dH (400MHz, CDCl3)
m/z (TOF FI) 551 (M+, 97%) 509 (M+ÀCH2@CHCH2,
D
0.74 (3H, d, J 7.0, CH3CHCH3), 0.99 (3H, d, J 7.0,
100).